Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$531M |
| 2 |
Kinder Morgan
KMI
|
+$496M |
| 3 |
IBM
IBM
|
+$253M |
| 4 |
CA
CA, Inc.
CA
|
+$213M |
| 5 |
Estee Lauder
EL
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$381M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$351M |
| 4 |
Apple
AAPL
|
+$333M |
| 5 |
Johnson & Johnson
JNJ
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.32% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.97% |
| 4 | Industrials | 10.35% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STNR
2601
DELISTED
STEINER LEISURE LTD
STNR
| $2.92M | ﹤0.01% |
63,259
-3,996
| -6% | -$166K |
|
2602
Coeur Mining
CDE
$19.3B
| $2.92M | ﹤0.01% |
571,838
+74,849
| +15% | +$334K |
|
2603
Inovio Pharmaceuticals
INO
$113M
| $2.91M | ﹤0.01% |
26,436
+3,661
| +16% | +$447K |
|
2604
Photronics
PLAB
$1.96B
| $2.9M | ﹤0.01% |
348,838
-516,544
| -60% | -$4.42M |
|
2605
Prothena Corp
PRTA
$455M
| $2.9M | ﹤0.01% |
139,438
+15,140
| +12% | +$316K |
|
|
DSPG
2606
DELISTED
DSP Group Inc
DSPG
| $2.9M | ﹤0.01% |
266,425
-8,017
| -3% | -$82.5K |
|
|
GHDX
2607
DELISTED
Genomic Health, Inc.
GHDX
| $2.89M | ﹤0.01% |
90,517
-2,739
| -3% | -$89.1K |
|
|
IMGN
2608
DELISTED
Immunogen Inc
IMGN
| $2.89M | ﹤0.01% |
473,890
+22,393
| +5% | +$205K |
|
|
GPX
2609
DELISTED
GP Strategies Corp.
GPX
| $2.89M | ﹤0.01% |
85,243
-13,083
| -13% | -$404K |
|
|
ERF
2610
DELISTED
Enerplus Corporation
ERF
| $2.88M | ﹤0.01% |
300,017
+31,150
| +12% | +$421K |
|
|
GOOD
2611
Gladstone Commercial Corp
GOOD
$626M
| $2.88M | ﹤0.01% |
167,502
+13,066
| +8% | +$229K |
|
2612
Ultragenyx Pharmaceutical
RARE
$2.61B
| $2.85M | ﹤0.01% |
65,050
-27,334
| -30% | -$1.25M |
|
2613
Honda
HMC
$41B
| $2.85M | ﹤0.01% |
96,617
-271,203
| -74% | -$8.43M |
|
2614
Dr. Reddy's Laboratories
RDY
$10.2B
| $2.85M | ﹤0.01% |
+282,145
| New | +$2.97M |
|
|
SCLN
2615
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $2.85M | ﹤0.01% |
324,817
-683
| -0.2% | -$5.53K |
|
2616
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
| $2.84M | ﹤0.01% |
71,156
+1,484
| +2% | +$57.6K |
|
2617
TransAlta
TAC
$4.05B
| $2.83M | ﹤0.01% |
312,391
+3,115
| +1% | +$29.9K |
|
|
TMX
2618
DELISTED
Terminix Global Holdings, Inc.
TMX
| $2.83M | ﹤0.01% |
157,831
+38,519
| +32% | +$643K |
|
2619
Banc of California
BANC
$3.13B
| $2.83M | ﹤0.01% |
246,484
+66,822
| +37% | +$759K |
|
|
REIS
2620
DELISTED
Reis, Inc.
REIS
| $2.82M | ﹤0.01% |
107,768
+29,485
| +38% | +$707K |
|
|
OPB
2621
DELISTED
Opus Bank Common Stock
OPB
| $2.81M | ﹤0.01% |
99,226
+78,754
| +385% | +$2.2M |
|
|
ELRC
2622
DELISTED
ELECTRO RENT CORP
ELRC
| $2.81M | ﹤0.01% |
200,510
-29,877
| -13% | -$429K |
|
|
XNPT
2623
DELISTED
XENOPORT, INC.
XNPT
| $2.81M | ﹤0.01% |
320,834
+9,941
| +3% | +$73K |
|
|
LF
2624
DELISTED
LEAPFROG ENTERPRISES INC.
LF
| $2.81M | ﹤0.01% |
594,981
+2,579
| +0.4% | +$13.7K |
|
2625
WisdomTree Japan Hedged Equity Fund
DXJ
$7.53B
| $2.79M | ﹤0.01% |
56,601
+24,409
| +76% | +$1.27M |
|
Similar funds
Bank of New York Mellon's Q4 2014 Portfolio in Review
As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
- Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
- Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
- Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
- Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
- Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.
Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.